Pearl Bio
Build next-gen Biomaterials for Smart Biologics
- Business Model
- B2B
- Website
- pearlbio.com
- Last Round
- SeedAug 2023
- Rounds
- 1
About
Synthetic biology company using genome and ribosome engineering to produce novel biologics with diverse chemistries.
Summary
Pearl Bio is a Biotech company based in United States. Its most recent funding was a Seed round in Aug 2023. Investors include Khosla Ventures and US National Science Foundation.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.